Article
Activation of the aryl hydrocarbon receptor in inflammatory bowel disease: insights from gut microbiota
24 Oct 2023
Abstract excerpt
Inflammatory bowel disease (IBD) is a chronic inflammatory intestinal disease that affects more than 3.5 million people, with rising prevalence. It deeply affects patients' daily life, increasing the burden on patients, families, and society. Presently, the etiology of IBD remains incompletely clarified, while emerging evidence has demonstrated that altered gut microbiota and decreased aryl hydrocarbon receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
